as 07-26-2024 4:00pm EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Founded: | 2011 | Country: | Switzerland |
Employees: | N/A | City: | N/A |
Market Cap: | 309.2M | IPO Year: | 2021 |
Target Price: | $7.33 | AVG Volume (30 days): | 47.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.12 | EPS Growth: | N/A |
52 Week Low/High: | $2.13 - $7.37 | Next Earning Date: | 08-06-2024 |
Revenue: | $64,184,000 | Revenue Growth: | 26.68% |
Revenue Growth (this year): | 28.97% | Revenue Growth (next year): | 28.39% |
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
PR Newswire
2 days ago
PR Newswire
2 days ago
PR Newswire
4 days ago
Simply Wall St.
12 days ago
Medical Device Network
22 days ago
PR Newswire
23 days ago
GlobeNewswire
a month ago
The information presented on this page, "SOPH SOPHiA GENETICS SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.